Ann Biol Clin (Paris)

1. GABSI H, Audenet F, Verkarre V, Gibault L, et al
   [Unusual bone marrow metastasis revealed by recurrent haematuria].
   Ann Biol Clin (Paris). 2025;83:551-556.
   

   >> Share

   
   

   
   Biochem Biophys Res Commun

2. PANG Y, Liu T, Wu X, Chen J, et al
   REV3L as a prognostic biomarker and therapeutic target in bladder urothelial carcinoma.
   Biochem Biophys Res Commun. 2025;790:152909.
   

   >> Share

   
   

   
   Biomed Pharmacother

3. KUNG ML, Chu TH, Hsieh S, Li CC, et al
   Phenolic zingerone nanoparticles impede cell cycle progression to compete against human urothelial carcinoma.
   Biomed Pharmacother. 2025;192:118675.
   

   >> Share

   
   

   
   BJU Int

4. ABDULMAJEED A, Bekiroglu F, Aydin A, Laguna P, et al
   Guidelines adherence in non-muscle-invasive bladder cancer: a global survey of 3595 participants.
   BJU Int. 2025 Nov 18. doi: 10.1111/bju.70079.
   

   >> Share

   
   
5. PACE KJC, Kwong JCC, Randhawa H, Ringa M, et al
   Risk of metachronous upper tract urothelial carcinoma following non-muscle-invasive bladder cancer.
   BJU Int. 2025 Nov 19. doi: 10.1111/bju.70085.
   

   >> Share

   
   

   
   BMC Med Imaging

6. WANG Y, Xiao W, Zhang Z, Wu Y, et al
   The clinical study of preoperative normalized apparent diffusion coefficient of 3.0-T MRI in predicting muscular invasion of bladder cancer.
   BMC Med Imaging. 2025;25:468.
   

   >> Share

   
   

   
   BMC Urol

7. LIU X, Sun S, Wang H, Yang S, et al
   Investigation on the current status of secondary transurethral resection for bladder cancer among Chinese urologists and construction of an acceptance prediction model.
   BMC Urol. 2025;25:292.
   

   >> Share

   
   

   
   Braz J Anesthesiol

8. MATTOS SLDL, Damiao R, Carrerette FB, Carneiro APL, et al
   An anesthetic perspective on transoperative complications in open versus robot-assisted radical cystectomy: a five-year retrospective study.
   Braz J Anesthesiol. 2025;75:844674.
   

   >> Share

   
   

   
   Cancer Lett

9. CHEN D, Li X, Zhao G, Zhang C, et al
   Transglutaminase 2 facilitates metastasis of basal-like bladder cancer by sustaining MVP-mediated MAPK/ERK1/2 signaling activation.
   Cancer Lett. 2025;636:218146.
   

   >> Share

   
   

   
   Cancer Manag Res

10. LI J, Bai L, Yan S, Niu J, et al
    Fear of Cancer Recurrence and Its Associated Factors in Bladder Cancer Patients of Different Age Stages: A Cross-Sectional Study.
    Cancer Manag Res. 2025;17:2653-2664.
    

    >> Share

    
    

    
    Cancer Med

11. ARAI O, Yanagihara Y, Arai H, Watanabe R, et al
    CDH11 Contributes to Bladder Cancer Progression via Regulation of Mitochondrial Energy Metabolism.
    Cancer Med. 2025;14:e71399.
    

    >> Share

    
    

    
    Clin Exp Med

12. LI Y, Zhao B, Gao W, Wu Y, et al
    LDB2 is a novel diagnostic and prognostic biomarker and inhibits bladder cancer metastasis by activating p38 MAPK/ERK1/2/JNK signaling pathway.
    Clin Exp Med. 2025;26:9.
    

    >> Share

    
    

    
    Clin Exp Metastasis

13. PICHLER R, Klinglmair G, Binz K, Grande E, et al
    Time to metastasis as a prognostic factor in metastatic urothelial carcinoma: results from the ARON-2 study.
    Clin Exp Metastasis. 2025;43:1.
    

    >> Share

    
    

    
    Clin Genitourin Cancer

14. RAJA IYUB MJ, Prabhakar P, Sakthivel DK, Chandrasekaran A, et al
    Metastasis Profile and Survival Outcomes of Metastatic Non-Muscle Invasive Bladder Cancer: A National Cancer Database Analysis.
    Clin Genitourin Cancer. 2025;24:102462.
    

    >> Share

    
    

    
    Clin Transl Oncol

15. SOTELO M, Pelaez M, Basterretxea L, Varga E, et al
    Avelumab maintenance in advanced urothelial carcinoma: real-world data from Northern Spain (AVEBLADDER study).
    Clin Transl Oncol. 2025;27:4481-4492.
    

    >> Share

    
    

    
    Cureus

16. IKARASHI D, Nozaki Y, Kikuchi K, Ariga H, et al
    Clinical Outcome and Safety of Combined Radiation Therapy and Maintenance Avelumab for Bladder Cancer: A Case Series.
    Cureus. 2025;17:e94938.
    

    >> Share

    
    

    
    Curr Cancer Drug Targets

17. LI H, Dai F, Zhang Y, Li X, et al
    Integrative Deep Learning from H&E Images Reveals Prognostically Distinct Pathology-Based Subtypes in Bladder Cancer.
    Curr Cancer Drug Targets. 2025 Nov 20. doi: 10.2174/0115680096434051251113094536
    

    >> Share

    
    

    
    Diabetes Metab

18. LU YC, Chang CH, Ho CH, Hong JH, et al
    SGLT2 inhibitor and urothelial carcinoma incidence in type 2 diabetes patients.
    Diabetes Metab. 2025;51:101694.
    

    >> Share

    
    

    
    Discov Oncol

19. WU G, Fan C, Ma X, Yao D, et al
    Utilizing a novel mitochondrial-related gene signature for predicting the prognosis and immunological impact in bladder cancer.
    Discov Oncol. 2025;16:2123.
    

    >> Share

    
    
20. SU P, Yang Y, Luo X, Zhang N, et al
    Research progress on the role of AGC kinase family in bladder cancer.
    Discov Oncol. 2025 Nov 20. doi: 10.1007/s12672-025-03977.
    

    >> Share

    
    
21. HAN X, Li L, Jia Y, Ai L, et al
    DCUN1D5 is a novel potential biomarker for predicting the prognosis of bladder cancer.
    Discov Oncol. 2025 Nov 20. doi: 10.1007/s12672-025-04082.
    

    >> Share

    
    
22. CAO K, Shi Y, Wu B, Shi H, et al
    Single cell RNA sequencing decodes cellular heterogeneity and identifies prognostic immune signatures in bladder cancer microenvironment.
    Discov Oncol. 2025 Nov 20. doi: 10.1007/s12672-025-03878.
    

    >> Share

    
    

    
    Eur Urol Focus

23. CRUPI E, Necchi A, Kamat AM
    Bladder Preservation After Neoadjuvant Therapy for Muscle-invasive Bladder Cancer in the Current Era: Myth and Reality.
    Eur Urol Focus. 2025 Nov 18:S2405-4569(25)00303.
    

    >> Share

    
    

    
    Eur Urol Oncol

24. PICCOLINI A, Moretto S, Fasulo V, Uleri A, et al
    Prognostic Role of Different T1 Substaging Systems on Recurrence and Progression in Non-muscle-invasive Bladder Cancer: A Systematic Review and Meta-analysis.
    Eur Urol Oncol. 2025 Nov 14:S2588-9311(25)00286.
    

    >> Share

    
    
25. CERRATO C, Roupret M, Mir MC
    Circulating Tumor DNA in Muscle-invasive Bladder Cancer: Promise, Pitfalls, and Path Forward.
    Eur Urol Oncol. 2025 Nov 18:S2588-9311(25)00289.
    

    >> Share

    
    

    
    Front Immunol

26. LU L, Wang F, Wang Z, Guo S, et al
    Immune snapshots along the inflammation-to-cancer road in bladder urothelium.
    Front Immunol. 2025;16:1685237.
    

    >> Share

    
    

    
    Front Oncol

27. ZHU Y, Tang Z, Lu Z, Gao D, et al
    Mechanism of active component beta-sitosterol from Myristica fragrans inducing apoptosis in bladder cancer cells via regulating the BCL-2/BAX/caspase-3 pathway.
    Front Oncol. 2025;15:1698721.
    

    >> Share

    
    
28. HOU J, Ding Y, Feng R, Wang Y, et al
    Explainable machine learning model predicts response to adjuvant therapy after radical cystectomy in bladder cancer.
    Front Oncol. 2025;15:1664965.
    

    >> Share

    
    

    
    Genes Dis

29. LIU L, Wan X, Liu S, Yu C, et al
    Single-cell molecular communications and transcriptional regulatory dynamics of T cell immunotherapy in bladder cancer.
    Genes Dis. 2025;13:101760.
    

    >> Share

    
    

    
    Int J Surg

30. CHEN XR, Tan XY, Zhang ZL, Yuan JS, et al
    CHMP4C promote the malignant progression of bladder cancer by regulating the PI3K/AKT pathway.
    Int J Surg. 2025 Nov 14. doi: 10.1097/JS9.0000000000003726.
    

    >> Share

    
    

    
    J Biol Chem

31. LIN P, Xing Z, Hong Y, Xu H, et al
    Integrin beta4 Drives Immune Evasion and Therapeutic Resistance to PD-1 blockade in Bladder Cancer via MEK/ERK Signaling.
    J Biol Chem. 2025 Nov 13:110941. doi: 10.1016/j.jbc.2025.110941.
    

    >> Share

    
    

    
    J Biomed Inform

32. WANG X, Preston A, Aning J, Zhou SM, et al
    Unveiling novel bladder cancer associations from multicentred primary and secondary care electronic health records by machine learning: a case-control study.
    J Biomed Inform. 2025;172:104959.
    

    >> Share

    
    

    
    J Cancer Surviv

33. SAHIN MF, Akgul M, Akpinar C, Bolat D, et al
    What do the current popular artificial intelligence chatbots offer us regarding patient information? Comparison of responses from the ten most popular chatbots about bladder cancer.
    J Cancer Surviv. 2025 Nov 19. doi: 10.1007/s11764-025-01921.
    

    >> Share

    
    

    
    J Control Release

34. SUN L, Qin X, Liu D, Zuo W, et al
    A multifunctional M1-like cell vehicle to intravesically deliver ICG for photodynamic therapy of bladder cancer.
    J Control Release. 2025 Nov 18:114428. doi: 10.1016/j.jconrel.2025.114428.
    

    >> Share

    
    

    
    J Med Econ

35. BELSEY J, Lapon J
    Hexaminolevulinate-enhanced photodynamic diagnosis in the management of non-muscle-invasive bladder cancer (NMIBC): the influence of differing European health care payment systems on the potential financial impact of adoption.
    J Med Econ. 2025;28:1999-2009.
    

    >> Share

    
    

    
    J Nat Med

36. OZ-BEDIR BE, Ercan E, Terzi E, Ozdemir-Sanci T, et al
    Theobromine as a molecular switch: targeting Nrf2 pathway in invasive and non-invasive bladder cancer.
    J Nat Med. 2025 Nov 16. doi: 10.1007/s11418-025-01961.
    

    >> Share

    
    

    
    J Urol

37. WALD G, Lang J, Alkazemi H, Zhang A, et al
    Combination Strategies to Enhance Bacillus Calmette-Guerin Efficacy for Non-Muscle Invasive Bladder Cancer.
    J Urol. 2025 Nov 21:101097JU0000000000004848. doi: 10.1097/JU.0000000000004848.
    

    >> Share

    
    

    
    JCO Oncol Pract

38. SADEGHI S, Lara PN Jr, Necchi A, Gill PS, et al
    Systemic Therapy for Muscle-Invasive Urothelial Carcinoma of the Bladder (Muscle-Invasive Bladder Cancer): Insights From Real-World Data.
    JCO Oncol Pract. 2025 Nov 18:OP2500464. doi: 10.1200/OP-25-00464.
    

    >> Share

    
    

    
    Jpn J Clin Oncol

39. ISHIKAWA Y, Tanaka H, Kobayashi M, Fujiwara M, et al
    Bladder region-specific analysis of the diagnostic performance of oral 5-aminolevulinic acid fluorescence cystoscopy in non-muscle-invasive bladder cancer.
    Jpn J Clin Oncol. 2025 Nov 15:hyaf171. doi: 10.1093.
    

    >> Share

    
    

    
    Medicine (Baltimore)

40. LIU X, Meng J, Huang B, Jin P, et al
    Vesicocolic fistula in myasthenia gravis patient: A case report.
    Medicine (Baltimore). 2025;104:e45586.
    

    >> Share

    
    

    
    Mod Pathol

41. BALESTRI I, Ivanova VS, Gasljevic G, von Gunten M, et al
    Exploring the genetic landscape of primary marginal zone lymphoma of the urinary bladder.
    Mod Pathol. 2025 Jul 9:100838. doi: 10.1016/j.modpat.2025.100838.
    

    >> Share

    
    

    
    Mol Genet Genomics

42. DOU X, Ma X, Meng W, Zhang W, et al
    Retraction Note: HEATR3 involved in the cell proliferation, metastasis and cell cycle development of bladder cancer acts as a tumor suppressor.
    Mol Genet Genomics. 2025;300:105.
    

    >> Share

    
    

    
    Nat Commun

43. LIU Z, Joshi R, Zhou Z, Liu F, et al
    Self-driven electrical triggering system activates tunneling nanotube highways to enhance drug delivery in bladder cancer therapy.
    Nat Commun. 2025;16:10093.
    

    >> Share

    
    

    
    Nat Med

44. O'LEARY K
    Liquid biopsy-guided adjuvant therapy in bladder cancer.
    Nat Med. 2025 Nov 14. doi: 10.1038/d41591-025-00065.
    

    >> Share

    
    

    
    Oncogene

45. DONG Y, Jiang X, Yang X, Zhang J, et al
    SQLE drives bladder cancer progression by boosting mitochondrial oxidative phosphorylation.
    Oncogene. 2025 Nov 18. doi: 10.1038/s41388-025-03626.
    

    >> Share

    
    

    
    Pathologica

46. KHEDKAR R, Kaur R, Rane S, Prakash G, et al
    Lymphoepithelioma-like carcinoma of urinary bladder - a rare subtype of urothelial carcinoma: a series of 12 cases.
    Pathologica. 2025;117:409-417.
    

    >> Share

    
    

    
    PeerJ

47. HAN K, Wang F, Wang R, Kong Q, et al
    The CD8(+)/Foxp3(+) ratio, but not the number of OX40(+) TILs, is an independent predictor of tumor recurrence in non-muscle-invasive bladder cancer: a retrospective study.
    PeerJ. 2025;13:e20322.
    

    >> Share

    
    

    
    Per Med

48. DE MORAES FCA, Rego LHRM, Morbach V, de Lima MPP, et al
    MYC variant at 8q24 increases susceptibility to urinary bladder cancer: a meta-analysis of 53,957 individuals.
    Per Med. 2025 Nov 21:1-9. doi: 10.1080/17410541.2025.2592528.
    

    >> Share

    
    

    
    Photodiagnosis Photodyn Ther

49. KHATAMI F, Sharifkazemi H, Taheri D, Oskouie IM, et al
    Evaluating the Impact of Febuxostat on 5-Aminolevulinic Acid-Based Photodynamic Therapy in Bladder Cancer Cell Lines.
    Photodiagnosis Photodyn Ther. 2025 Nov 19:105286.
    

    >> Share

    
    

    
    Sci Rep

50. SUN D, Hadjiiski L, Bruno G, Gormley J, et al
    Evaluating the reliability of large language models for clinical data extraction in bladder cancer prognosis.
    Sci Rep. 2025 Nov 21. doi: 10.1038/s41598-025-27593.
    

    >> Share

    
    
51. WEN Y, Ming Z, Xiong Y, Li H, et al
    Small cell size circulating tumor cells predict the prognosis of high-risk non-muscle invasive bladder cancer patients.
    Sci Rep. 2025;15:40909.
    

    >> Share

    
    
52. KHAN M, de Groot AG, Cornel EB, van der Heijden AG, et al
    Explainable and likelihood aware AI framework for MRI-based pixel-level bladder tumour prediction.
    Sci Rep. 2025;15:40760.
    

    >> Share

    
    
53. CHEN X, Tian Y, Li T, Zhong Q, et al
    Circ_0003266 suppresses bladder cancer progression by modulating the miR-503-5p/SMAD7/TGF-beta signaling axis.
    Sci Rep. 2025;15:40783.
    

    >> Share

    
    
54. GAO C, Wang X, Sun Y, An F, et al
    CircPSMA4 as a novel circular RNA enhances the proliferation migration invasion and metabolism of bladder cancer cells through the miR-767-3p/HIF1A pathway.
    Sci Rep. 2025;15:40468.
    

    >> Share

    
    
55. KANG Q, Kong X, Najjar G, Azoitei A, et al
    Loss of p190A RhoGAP induces aneuploidy and enhances bladder cancer cell migration and invasion by modulating actin dynamics.
    Sci Rep. 2025;15:40399.
    

    >> Share

    
    
56. TANG Z, Peng J, Wei Z, Wu S, et al
    Comprehensive analysis of ALYREF gene expression and its correlation with immunotherapy efficacy and circulating tumor cells in bladder cancer.
    Sci Rep. 2025;15:40032.
    

    >> Share

    
    

    
    Semin Diagn Pathol

57. KHORSANDI N, Porten S, VandenBussche CJ, Greenland N, et al
    Bridging Perspectives: Integrating urologist and cytopathologist insights of urine cytology.
    Semin Diagn Pathol. 2025;42:150960.
    

    >> Share

    
    

    
    Ultrasound Med Biol

58. ZHUANG J, Chen Y, Zheng W, Lian G, et al
    Prediction of HER2 Expression in Urothelial Carcinoma of the Bladder: Are Ultrasound-based Radiomic Features Significant?
    Ultrasound Med Biol. 2026;52:190-200.
    

    >> Share

    
    

    
    Urol Oncol

59. ARULRAJ K, Aggarwal N, Nayak B, Nayyar R, et al
    Single dose perioperative intravesical instillation of gemcitabine versus mitomycin-C following resection of non-muscle invasive bladder cancer: A randomized controlled trial.
    Urol Oncol. 2025 Nov 19:S1078-1439(25)00443.
    

    >> Share

    
    
60. MOYER JA, Mi L, Nguyen MV, Durant AM, et al
    Real-world outcomes of nadofaragene firadenovec for BCG-unresponsive non-muscle-invasive bladder cancer: A multicenter experience.
    Urol Oncol. 2025 Nov 17:S1078-1439(25)00442.
    

    >> Share

    
    

    
    Vet Comp Oncol

61. PETERSON HM, Keuler NS, Trepanier LA
    Urinary Aromatic Amine Exposures in Pet Dogs With Urothelial Carcinoma and Unaffected Controls.
    Vet Comp Oncol. 2025;23:597-605.
    

    >> Share

    
    
62. THOMAS R, Luff JA, Dickey AN, Dillon MN, et al
    Genomic Evaluation of Canine Prostatic Carcinomas as a Model for the Human Disease: or 'UC or not UC - that is the question'.
    Vet Comp Oncol. 2025;23:528-548.
    

    >> Share

    
    

    
    World J Urol

63. RINDERKNECHT E, Claps F, Bostrom PJ, Shariat SF, et al
    Is histological grade a useful parameter in muscle-invasive urothelial bladder cancer? Results from a multicenter study on the impact of different grading systems on disease-free survival after upfront radical cystectomy.
    World J Urol. 2025;43:705.
    

    >> Share

    
    
64. BEKIROGLU F, Abdulmajeed A, Aydin A, Laguna P, et al
    The worldwide adoption of enhanced endoscopic imaging in diagnosis and treatment of non-muscle invasive bladder cancer (NMIBC): snapshot analysis from a global survey.
    World J Urol. 2025;43:693.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share